What is Vaxcyte Inc (PCVX) stock price today?

Vaxcyte Inc (PCVX) currently trades at $57.32 per share. The stock has a market capitalization of $8.28B and a P/E ratio of —x.

Is PCVX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Vaxcyte Inc has a Smart Value Score of 27/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is 8.94.

Is Vaxcyte Inc financially healthy?

Vaxcyte Inc's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of 8.94 places it in the safe zone.

PCVX

Vaxcyte Inc

NASDAQ: PCVX · HEALTHCARE · BIOTECHNOLOGY

$57.32

-2.40% today

Updated 2026-04-29

Market cap

$8.28B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-5.63

Dividend yield

—

52W range

$28 – $65

Volume

1.3M

Market cap

$8.28B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-5.63

Dividend yield

—

52W range

$28 – $65

Volume

1.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

7.3

Quality

B+

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

8.9

Altman Z-Score

Safe zone

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$109.00

+90.16%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy9 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Altman Z 8.94 — safe zone

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-230.40M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-223.49M	$-402.27M	$-463.93M	$-766.63M	$-246.51M
EPS	—	—	—	—	$-5.63
Free cash flow	$-176.44M	$-364.67M	$-475.05M	$-669.29M	$-230.40M
Profit margin	—	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-04-07	COWAN, ELVIA	Sale	3,000	—
2026-04-07	COWAN, ELVIA	Sale	3,000	$60.00
2026-04-01	WASSIL, JIM	Sale	1,412	$58.14

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
PCVX	$8.28B	27	4.3	3.0	5.0	7.3	—	Avoid
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Vaxcyte Inc trades at $57.32. Our Smart Value Score of 27/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 8.94, it sits in the safe zone.

Frequently asked questions

What is Vaxcyte Inc's stock price?

Vaxcyte Inc (PCVX) trades at $57.32.

Is Vaxcyte Inc overvalued?

Smart Value Score 27/100 (Grade F, Strong Sell).

What is the price target of Vaxcyte Inc (PCVX)?

The analyst target price is $109.00, representing +90.2% upside from the current price of $57.32.

Piotroski F-Score?

3/9 — weak financial health.

Altman Z-Score?

8.94 — safe zone.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-25.60%

Beta1.39

50D MA$58.68

200D MA$45.97

Shares out0.14B

Float0.13B

Short ratio—

Avg volume1.3M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

PCVX vs LLY →PCVX vs JNJ →PCVX vs ABBV →Stock screener →